Ubie, a Tokyo, Japan-based healthcare AI startup that provides AI medical interview systems for hospitals and general practices, announced that it raised $26.2 million in its first Series C funding.
New investors in the round include Norinchukin Capital Co., Ltd., NVenture Capital Limited (wholly owned subsidiary of NEC Capital Solutions Limited), The Dai-ichi Life Insurance Company, Limited, and Egg FORWARD, Inc., while existing investors include SUZUKEN CO., LTD. To date, Ubie has raised $59.8 million.
The Series C funding will be used to fuel business growth in Japan and the United States, as well as to build a medical data platform that connects patients, medical institutions, and pharmaceutical companies.
Company: Ubie, Inc.
Round: Series C
Funding Month: Aug 2022
Lead Investors: Norinchukin Capital Co., Ltd., NVenture Capital Limited, The Dai-ichi Life Insurance Company Limited, Egg FORWARD, Inc., SUZUKEN CO., LTD.
Additional Investors: SUZUKEN CO., LTD.
Company Website: https://company.ubiehealth.com/
Software Category: Healthcare AI
About the Company: Ubie is a Japanese health-tech startup founded by a medical doctor and an engineer in 2017. Using AI as its core technology, the company develops and provides an AI-powered patient questionnaire that guides patients with symptoms to appropriate medical care and improves operational efficiency in the medical field. Ubie is promoting the creation of a society in which anyone can access medical care that suits them best.